Fundraising Fox

Corinne Nevinny

Investor

Managing Director at Avestria Ventures

California

Writes $100K – $5M checks Β· typically $1.5M

Find your path to Corinne

200 people in our graph share verified history with Corinne β€” schools, employers, funds. One of them is your warm intro.

Neil RimerunlockedCorinne: together at Stanford University (1981)
Γ—4Corinne: together at Harvard Business School
Γ—7Corinne: together at Stanford University

About

Corinne Nevinny studied industrial engineering at Stanford and earned an MBA from Harvard Business School. She worked as a health care investment banker at firms including Kidder Peabody, Dillon Read, and UBS before moving into operating roles as CFO of Tularik, where she led its IPO, and later CFO and President of Global Operations at Edwards Lifesciences. She co-founded Avestria Ventures in 2019 with Linda Greub, and has served on the boards of several publicly traded therapeutics companies.

Invests in

BiotechHealthtechMedical Devices

Experience

  1. WhtNowCo-Foundercurrent2021 β€” presentCalifornia, United States
  2. Avestria VenturesManaging Directorcurrent2018 β€” present
  3. LMNVC LLCGeneral Partnercurrent2010 β€” presentLos Angeles
  4. Insulet CorporationBoard Member2019 β€” 2024Acton, Massachusetts
  5. Neurocrine BiosciencesMember of BOD and Chair of Audit Committee2004 β€” 2018
  6. Avanir PharmaceuticalsMember of BOD, Audit Committee Chair2013 β€” 2015
  7. Onyx Pharmaceuticals (acquired by Amgen 2013)Member of BOD and Chair of Audit Committee2004 β€” 2013
  8. Edwards LifesciencesGeneral Manager Cardiac Surgery Systems and Vascular2009 β€” 2010
  9. Edwards LifesciencesPresident Global Operations2006 β€” 2009
  10. Edwards LifesciencesCFO, Treasurer2003 β€” 2005
  11. Tularik (acquired by Amgen)CFO1998 β€” 2003

Skills & more

General Manager $200m med device business @ EW6Mergers & Acquisitions24Corporate Development7Cross-functional Team Leadership17Business Strategy10Biotechnology6Strategic Planning7Start-ups34Competitive Analysis5Process Improvement3Mergers4Medical Devices7
+5 moreFinancial ModelingProduct ManagementDue DiligenceVenture CapitalCommercialization

From Corinne's professional profile.

Investments

Board seats

AvanirInsulet CorporationNeurocrine BiosciencesOnyx Pharmaceuticals

Per the firm's website.

Colleagues at Avestria Ventures

Frequently asked questions

Who is Corinne Nevinny?
Corinne Nevinny studied industrial engineering at Stanford and earned an MBA from Harvard Business School. She worked as a health care investment banker at firms including Kidder Peabody, Dillon Read, and UBS before moving into operating roles as CFO of Tularik, where she led its IPO, and later CFO and President of Global Operations at Edwards Lifesciences. She co-founded Avestria Ventures in 2019 with Linda Greub, and has served on the boards of several publicly traded therapeutics companies.
Where does Corinne Nevinny work?
Corinne Nevinny is Managing Director at Avestria Ventures.
What does Corinne Nevinny invest in?
Corinne Nevinny invests in Biotech, Healthtech, Medical Devices.
What check size does Corinne Nevinny write?
Corinne Nevinny typically writes checks of $100K – $5M.
What boards does Corinne Nevinny sit on?
Corinne Nevinny holds tracked board seats at Avanir, Insulet Corporation, Neurocrine Biosciences, Onyx Pharmaceuticals.
Where did Corinne Nevinny go to school?
Corinne Nevinny studied at Harvard Business School (Master of Business Administration (MBA)); Stanford University (Bachelor of Science (BS), Industrial Engineering).

Same school

Shared employers